Ultragenyx Pharmaceutical Inc. Peer Comparison

Metric Value Ranking
Market Cap $3.3 Billion 6/16 ALNY
$32.7B		 UTHR
$13.6B		 INCY
$11.4B		 RVMD
$7.5B		 MRTX
$4.1B		 RARE
$3.3B		 CRNX
$2.9B		 APLS
$2.2B		 DAWN
$653.8M		 KURA
$498.7M		 ARVN
$482.5M		 TERN
$264.6M		 INZY
$85.9M		 ABOS
$60.6M		 PDSB
$53.0M		 XFOR
$18.8M
Gross Margin 90% 5/16 KURA
100%		 ARVN
100%		 INCY
92%		 MRTX
91%		 RARE
90%		 UTHR
90%		 DAWN
90%		 ALNY
83%		 APLS
81%		 XFOR
79%		 CRNX
0%		 PDSB
0%		 RVMD
0%		 INZY
0%		 TERN
0%		 ABOS
0%
Profit Margin -81% 13/16 UTHR
41%		 INCY
17%		 CRNX
0%		 PDSB
0%		 RVMD
0%		 INZY
0%		 TERN
0%		 ABOS
0%		 ALNY
-14%		 APLS
-17%		 KURA
-36%		 ARVN
-76%		 RARE
-81%		 MRTX
-100%		 XFOR
-100%		 DAWN
-100%
EBITDA margin -66% 6/16 UTHR
58%		 INCY
29%		 APLS
-11%		 ALNY
-26%		 KURA
-31%		 RARE
-66%		 ARVN
-96%		 CRNX
-100%		 PDSB
-100%		 RVMD
-100%		 INZY
-100%		 TERN
-100%		 ABOS
-100%		 DAWN
-221%		 MRTX
-1049%		 XFOR
-2579%
Quarterly Revenue $164.9 Million 5/16 INCY
$1.2B		 UTHR
$735.9M		 ALNY
$593.2M		 APLS
$212.5M		 RARE
$164.9M		 ARVN
$59.2M		 KURA
$53.9M		 DAWN
$29.2M		 MRTX
$16.4M		 XFOR
$1.4M		 CRNX
$0		 PDSB
$0		 RVMD
$0		 INZY
$0		 TERN
$0		 ABOS
$0
Quarterly Earnings -$133.4 Million 14/16 UTHR
$301.3M 		INCY
$201.2M 		PDSB
-$8.0M 		KURA
-$19.2M 		TERN
-$21.8M 		INZY
-$27.1M 		APLS
-$36.4M 		ABOS
-$37.2M 		XFOR
-$39.8M 		ARVN
-$45.1M 		DAWN
-$65.7M 		CRNX
-$80.6M 		ALNY
-$83.8M 		RARE
-$133.4M 		MRTX
-$161.9M 		RVMD
-$194.6M
Quarterly Free Cash Flow -$80.2 Million 12/16 INCY
$363.8M 		KURA
$268.8M 		UTHR
$254.5M 		APLS
$19.3M 		PDSB
-$8.2M 		TERN
-$14.6M 		INZY
-$19.2M 		ABOS
-$27.2M 		DAWN
-$31.4M 		XFOR
-$33.0M 		CRNX
-$65.7M 		RARE
-$80.2M 		ARVN
-$84.4M 		ALNY
-$103.8M 		RVMD
-$139.5M 		MRTX
-$143.7M
Trailing 4 Quarters Revenue $560.2 Million 5/16 INCY
$4.2B		 UTHR
$2.9B		 ALNY
$2.2B		 APLS
$761.1M		 RARE
$560.2M		 ARVN
$263.4M		 DAWN
$57.5M		 KURA
$53.9M		 MRTX
$38.2M		 XFOR
$2.0M		 CRNX
$1.0M		 PDSB
$0		 RVMD
$0		 INZY
$0		 TERN
$0		 ABOS
$0
Trailing 4 Quarters Earnings -$569.2 Million 13/16 INCY
$1.2B 		UTHR
$735.9M 		ALNY
$593.2M 		APLS
$212.5M 		RARE
$164.9M 		ARVN
$59.2M 		KURA
$53.9M 		DAWN
$29.2M 		MRTX
$16.4M 		XFOR
$1.4M 		CRNX
-$0 		PDSB
-$0 		RVMD
-$0 		INZY
-$0 		TERN
-$0 		ABOS
-$0
Quarterly Earnings Growth -8% 11/16 ARVN
71% 		APLS
59% 		KURA
58% 		ALNY
39% 		UTHR
39% 		PDSB
27% 		MRTX
7% 		INCY
0% 		TERN
-4% 		DAWN
-7% 		RARE
-8% 		INZY
-26% 		CRNX
-34% 		RVMD
-68% 		ABOS
-125% 		XFOR
-1628%
Annual Earnings Growth 5% 7/16 XFOR
88% 		APLS
61% 		DAWN
52% 		ARVN
43% 		TERN
19% 		UTHR
17% 		RARE
5% 		RVMD
2% 		MRTX
-2% 		KURA
-8% 		CRNX
-28% 		INZY
-43% 		ABOS
-85% 		INCY
-95% 		ALNY
-191% 		PDSB
-45802%
Quarterly Revenue Growth 29% 7/16 DAWN
5116% 		KURA
4143% 		ARVN
237% 		MRTX
202% 		APLS
67% 		ALNY
35% 		RARE
29% 		UTHR
20% 		INCY
16% 		CRNX
0% 		PDSB
0% 		XFOR
0% 		RVMD
0% 		INZY
0% 		TERN
0% 		ABOS
0%
Annual Revenue Growth 33% 6/16 DAWN
10163% 		KURA
4143% 		ARVN
334% 		APLS
79% 		MRTX
77% 		RARE
33% 		UTHR
18% 		INCY
12% 		CRNX
0% 		PDSB
0% 		XFOR
0% 		INZY
0% 		TERN
0% 		ABOS
0% 		ALNY
-19% 		RVMD
-100%
Cash On Hand $173.7 Million 9/16 UTHR
$1.7B 		INCY
$1.7B 		ALNY
$966.4M 		RVMD
$543.1M 		APLS
$411.3M 		CRNX
$264.5M 		MRTX
$258.7M 		KURA
$224.5M 		RARE
$173.7M 		TERN
$161.4M 		DAWN
$125.0M 		ARVN
$100.5M 		XFOR
$55.7M 		PDSB
$41.7M 		ABOS
$35.6M 		INZY
$21.1M
Short Term Debt $10.3 Million 6/16 UTHR
$300.0M 		ALNY
$41.9M 		INZY
$15.4M 		RVMD
$12.9M 		PDSB
$12.6M 		RARE
$10.3M 		INCY
$10.0M 		MRTX
$8.0M 		CRNX
$7.2M 		APLS
$6.8M 		KURA
$4.5M 		ARVN
$1.8M 		XFOR
$1.3M 		TERN
$428,000 		ABOS
$133,000 		DAWN
$20,000
Long Term Debt $30.0 Million 9/16 ALNY
$1.3B		 APLS
$463.0M		 RVMD
$123.0M		 XFOR
$76.8M		 CRNX
$44.6M		 MRTX
$42.2M		 INCY
$33.5M		 INZY
$31.5M		 RARE
$30.0M		 ABOS
$28.6M		 KURA
$12.1M		 PDSB
$9.3M		 ARVN
$7.9M		 DAWN
$2.6M		 TERN
$919,000		 UTHR
$0
PE -1.00 3/16 INCY
349.93		 UTHR
11.38		 RARE
-1.00		 ALNY
-1.00		 KURA
-1.00		 MRTX
-1.00		 APLS
-1.00		 ARVN
-1.00		 CRNX
-1.00		 PDSB
-1.00		 XFOR
-1.00		 RVMD
-1.00		 INZY
-1.00		 TERN
-1.00		 DAWN
-1.00		 ABOS
-1.00
PS 5.88 7/16 CRNX
2764.72		 MRTX
107.82		 ALNY
15.11		 DAWN
11.38		 XFOR
9.39		 KURA
9.25		 RARE
5.88		 UTHR
4.73		 APLS
2.86		 INCY
2.69		 ARVN
1.83		 PDSB
-1.00		 RVMD
-1.00		 INZY
-1.00		 TERN
-1.00		 ABOS
-1.00
PB 12.57 2/16 ALNY
488.12		 RARE
12.57		 APLS
9.51		 MRTX
4.35		 RVMD
3.32		 INCY
3.31		 PDSB
2.79		 CRNX
2.17		 UTHR
2.11		 INZY
1.48		 DAWN
1.30		 KURA
1.21		 ARVN
0.86		 XFOR
0.85		 TERN
0.77		 ABOS
0.33
PC 18.98 2/16 ALNY
33.88		 RARE
18.98		 MRTX
15.92		 RVMD
13.86		 CRNX
10.86		 UTHR
8.01		 INCY
6.76		 APLS
5.29		 DAWN
5.23		 ARVN
4.80		 INZY
4.07		 KURA
2.22		 ABOS
1.70		 TERN
1.64		 PDSB
1.27		 XFOR
0.34
Liabilities to Equity 4.86 3/16 ALNY
62.20		 XFOR
5.61		 RARE
4.86		 APLS
2.87		 PDSB
1.39		 INZY
1.13		 ARVN
0.94		 KURA
0.84		 INCY
0.58		 ABOS
0.31		 MRTX
0.19		 DAWN
0.16		 UTHR
0.14		 RVMD
0.13		 CRNX
0.08		 TERN
0.05
ROA -0.38 12/16 UTHR
16% 		INCY
1% 		ALNY
-7% 		XFOR
-14% 		DAWN
-16% 		ARVN
-18% 		CRNX
-21% 		APLS
-22% 		KURA
-23% 		RVMD
-24% 		TERN
-24% 		RARE
-38% 		ABOS
-43% 		MRTX
-63% 		INZY
-83% 		PDSB
-43966%
ROE -2.23 14/16 UTHR
19% 		INCY
1% 		DAWN
-19% 		CRNX
-23% 		TERN
-26% 		RVMD
-27% 		ARVN
-35% 		KURA
-42% 		ABOS
-56% 		MRTX
-76% 		APLS
-87% 		XFOR
-90% 		INZY
-176% 		RARE
-223% 		ALNY
-415% 		PDSB
-104933%
Current Ratio 1.21 14/16 TERN
20.15		 CRNX
13.07		 RVMD
8.73		 UTHR
8.00		 DAWN
7.28		 MRTX
6.17		 ABOS
4.18		 INCY
2.73		 KURA
2.19		 ARVN
2.06		 INZY
1.88		 PDSB
1.72		 APLS
1.35		 RARE
1.21		 XFOR
1.18		 ALNY
1.02
Quick Ratio 0.49 16/16 INCY
349.93		 UTHR
11.38		 RARE
-1.00		 ALNY
-1.00		 KURA
-1.00		 MRTX
-1.00		 APLS
-1.00		 ARVN
-1.00		 CRNX
-1.00		 PDSB
-1.00		 XFOR
-1.00		 RVMD
-1.00		 INZY
-1.00		 TERN
-1.00		 DAWN
-1.00		 ABOS
-1.00
Long Term Debt to Equity 0.12 7/16 ALNY}
18.69		 XFOR}
3.47		 APLS}
2.03		 INZY}
0.54		 PDSB}
0.49		 ABOS}
0.16		 RARE}
0.12		 RVMD}
0.05		 MRTX}
0.04		 KURA}
0.03		 CRNX}
0.03		 INCY}
0.01		 ARVN}
0.01		 DAWN}
0.01		 UTHR}
0.00		 TERN}
0.00
Debt to Equity 0.16 6/16 ALNY
19.32		 XFOR
3.53		 APLS
2.06		 PDSB
1.15		 INZY
0.81		 RARE
0.16		 ABOS
0.16		 RVMD
0.06		 MRTX
0.05		 UTHR
0.05		 KURA
0.04		 CRNX
0.04		 ARVN
0.02		 INCY
0.01		 DAWN
0.01		 TERN
0.00
Burn Rate 1.27 12/16 KURA
10.78		 TERN
7.36		 APLS
7.27		 ALNY
6.69		 PDSB
3.64		 CRNX
3.14		 RVMD
2.68		 ARVN
2.19		 DAWN
1.90		 MRTX
1.56		 XFOR
1.29		 RARE
1.27		 ABOS
0.93		 INZY
0.65		 UTHR
-7.50		 INCY
-8.55
Cash to Cap 0.05 15/16 XFOR
2.97		 PDSB
0.79		 TERN
0.61		 ABOS
0.59		 KURA
0.45		 INZY
0.25		 ARVN
0.21		 APLS
0.19		 DAWN
0.19		 INCY
0.15		 UTHR
0.12		 CRNX
0.09		 RVMD
0.07		 MRTX
0.06		 RARE
0.05		 ALNY
0.03
CCR 0.60 13/16 ARVN
1.87		 INCY
1.81		 ALNY
1.24		 PDSB
1.04		 MRTX
0.89		 UTHR
0.84		 XFOR
0.83		 CRNX
0.82		 ABOS
0.73		 RVMD
0.72		 INZY
0.71		 TERN
0.67		 RARE
0.60		 DAWN
0.48		 APLS
-0.53		 KURA
-13.99
EV to EBITDA -29.07 14/16 INCY}
29.00		 UTHR}
28.76		 PDSB}
-1.00		 RVMD}
-1.00		 INZY}
-1.00		 TERN}
-1.00		 ABOS}
-1.00		 XFOR}
-1.11		 ARVN}
-6.92		 DAWN}
-8.23		 KURA}
-17.53		 MRTX}
-22.72		 CRNX}
-28.31		 RARE}
-29.07		 APLS}
-92.73		 ALNY}
-213.42
EV to Revenue 5.65 6/16 CRNX
2559.88		 MRTX
102.36		 XFOR
20.60		 ALNY
15.26		 DAWN
9.25		 RARE
5.65		 KURA
5.40		 UTHR
4.24		 APLS
2.93		 INCY
2.30		 ARVN
1.49		 PDSB
-1.00		 RVMD
-1.00		 INZY
-1.00		 TERN
-1.00		 ABOS
-1.00

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions